Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon F Keele

Showing results (181-190 of 230) with videos related to

Pageof 23
Sort By:
Nature Communications|August 19, 2015
Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infectionXing Pei Hao, Carissa M Lucero, Baris Turkbey, et al.
Cell Reports. Medicine|January 10, 2026
Anti-IL-15 treatment reduces acute lentivirus inflammation and signaling in the brainDaniel R Ram, Raja Mohan Gopalakrishnan, Malika Aid, et al.
Cell Reports. Medicine|February 26, 2026
Delayed viral rebound post-ART interruption in infant macaques given SIV-specific neutralizing antibodiesJenna S Powers, Katherine M Bricker-Holt, Brianna Williams, et al.
Nature|September 25, 2010
Origin of the human malaria parasite Plasmodium falciparum in gorillasWeimin Liu, Yingying Li, Gerald H Learn, et al.
AIDS Research and Human Retroviruses|May 1, 2023
Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop SummaryBrigitte E Sanders-Beer, Nancie M Archin, Zabrina L Brumme, et al.
The Journal of Experimental Medicine|December 5, 2025
Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defectKyle Rhodehouse, Carolin Zitzmann, Meghana Ravi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Molecular Therapy. Advances|May 15, 2026
<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV preventionChang Li, Anna K Anderson, Anne-Sophie Kuhlmann, et al.
Plos Pathogens|May 10, 2021
Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaquesRachele M Bochart, Kathleen Busman-Sahay, Stephen Bondoc, et al.
Plos Pathogens|April 19, 2023
Correction: Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaquesRachele M Bochart, Kathleen Busman-Sahay, Stephen Bondoc, et al.
Pageof 23

Showing results (181-190 of 230) with videos related to

Sort By:
Pageof 23
Nature Communications|August 19, 2015
Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infectionXing Pei Hao, Carissa M Lucero, Baris Turkbey, et al.
Cell Reports. Medicine|January 10, 2026
Anti-IL-15 treatment reduces acute lentivirus inflammation and signaling in the brainDaniel R Ram, Raja Mohan Gopalakrishnan, Malika Aid, et al.
Cell Reports. Medicine|February 26, 2026
Delayed viral rebound post-ART interruption in infant macaques given SIV-specific neutralizing antibodiesJenna S Powers, Katherine M Bricker-Holt, Brianna Williams, et al.
Nature|September 25, 2010
Origin of the human malaria parasite Plasmodium falciparum in gorillasWeimin Liu, Yingying Li, Gerald H Learn, et al.
AIDS Research and Human Retroviruses|May 1, 2023
Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop SummaryBrigitte E Sanders-Beer, Nancie M Archin, Zabrina L Brumme, et al.
The Journal of Experimental Medicine|December 5, 2025
Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defectKyle Rhodehouse, Carolin Zitzmann, Meghana Ravi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Molecular Therapy. Advances|May 15, 2026
<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV preventionChang Li, Anna K Anderson, Anne-Sophie Kuhlmann, et al.
Plos Pathogens|May 10, 2021
Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaquesRachele M Bochart, Kathleen Busman-Sahay, Stephen Bondoc, et al.
Plos Pathogens|April 19, 2023
Correction: Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaquesRachele M Bochart, Kathleen Busman-Sahay, Stephen Bondoc, et al.
Pageof 23